Initiation of growth arrest and apoptosis of MCF-7 mammary carcinoma cells by tributyrin, a triglyceride analogue of the short-chain fatty acid butyrate, is associated with mitochondrial activity

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1584-1591

  Heerdt, Barbara G ^a,b   Houston, Michele A ^a   Anthony, Gillian M ^a   Augenlicht, Leonard H ^a  

^a ALBERT EINSTEIN CANCER CENTER   (United States)

^b MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID DERIVATIVE; CYTOCHROME C; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P21; PROTEIN P53; TRIBUTYRIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL;

APOPTOSIS; BREAST NEOPLASMS; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; CYTOCHROME C GROUP; FEMALE; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; POLY(ADP-RIBOSE) POLYMERASES; TRIALKYLTIN COMPOUNDS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033119191     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Russo, J., and Russo, I. H. The etiopathogenesis of breast cancer prevention. Cancer Lett., 90: 81-89, 1995.
2. Ferguson, D. J. P., and Anderson, T. J. Morphological evaluation of cell turnover in relation to the menstrual cycle in the "resting" human breast. Br. J. Cancer, 44: 177-181, 1981.
3. Anderson, T. J., Ferguson, D. J. P., and Raab, G. M. Cell turnover in the "resting" human breast: influence of parity, contraceptive pill, age and laterality. Br. J. Cancer, 46: 376-382, 1982.
4. Going, J. J., Anderson, T. J., Barrersby, S., and Macintyre, C. C. A. Proliferative and secretory activity in human breast during natural and artificial menstrual cycles. Am. J. Pathol., 130: 193-204, 1988.
5. Allan, D. J., Howell, A., Roberts, S. A., Williams, G. T., Watson, R. J., Coyne, J. D., Clarke, R. B., Laidlaw, I. J., and Potten, C. S. Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocystic change and carcinoma of the premenopausal human breast. J. Pathol., 167: 25-32, 1992.
6. Planchon, P., Raux, H., Magnien, V., Ronco, G., Villa, P., Crepin, M., and Brouty-Boye, D. New stable butyrate derivatives alter proliferation and differentiation in human mammary cells. Int. J. Cancer, 48: 443-449, 1991.
7. Mandal, M., and Kumar, R. Bel-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. Cell Growth Differ., 7: 311-318, 1996.
8. Novagrodsky, A., Ovir, A., Ravid, A., Shkolnik, T., Stenzel, K. H., Rubin, A. L., and Zalaor, R. Effect of polar organic compounds in leukemia cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child. Cancer (Phila.), 51: 9-14, 1983.
9. Miller, A. A., Kurschel, E., Osieka, R., and Schmidt, C. G. Clinical pharmacology of sodium butyrate in patients with acute leukemia. Eur. J. Clin. Oncol., 23: 1283-1287, 1987.
10. Perrine, S. P., Ginder, G. D., Faller, D. V . Dover, G. H., Ikuta, T., Witkowsha, H. E., Cai, S. P., Vichinsky, E. P., and Olivieri, N. F. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the β-globin disorders. N. Engl. J. Med., 328: 81-86, 1993.
11. Sher, G. D., Ginder, G. D., Little, J., Yang, S., Dover, G. J., and Olivieri, N. F. Extended therapy with intravenous arginine butyrate in patients with β-hemoglobinopathies. N. Engl. J. Med., 332: 1606-1610, 1995.
12. Newmark, H. L., and Young, C. W. Butyrate and phenylacetate as differentiating agents: practical problems and opportunities. J. Cell Biochem., 22: 247-253, 1995.
13. Conley, B., Tait, N., Rosen, D., Sausville, E., Van Echo, D., and Egorin, M. Phase 1 and pharmacokinetics (PK) trial of oral tributyrin in patients (pts) with solid tumors. Proc. Am. Assoc. Cancer Res., 38: 222, 1997.
14. Snyderman, S. E., Morales, S., and Holt, L. E. J. The absorption of short-chain fats by premature infants. Arch. Dis. Child., 30: 83-84, 1955.
15. Chen, Z. X., and Breitman, T. R. Tributyrin: a prodrug of butyric acid for potential clinical application in differentiation therapy. Cancer Res., 54: 3494-3499, 1994.
16. Newmark, H. L., Lupton, J. R., and Young, C. W. Butyrate as a differentiating agent: pharmacokinetics, analogues, and current status. Cancer Lett., 78: 1-5, 1994.
17. Yuan, Z., Eiseman, J., Plasance, K., Sentz, D., Bigora, S., Fossler, M., Young, D., and Egorin, M. Plasma pharmacokinetics of butyrate after the administration of tributyrin and Na butyrate to mice and rats. Proc. Am. Assoc. Cancer Res., 35: 429, 1994.
18. Soule, H. D., Vazguez, J., Long, A., Albert, S., and Brennan, M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst., 51: 1409-1416, 1973.
19. Heerdt, B. G., Houston, M. A., Anthony, G. M. and Augenlicht, L. H. Mitochondrial membrane potential (delta psi mt) in the coordination of p53-independent proliferation and apoptosis pathways in human colonic carcinoma cells. Cancer Res., 58: 2869-2875, 1998.
20. Heerdt, B. G., Houston, M. A., and Augenlicht, L. H. Short-chain fatty acid initiated cell cycle arrest and apoptosis of colonic epithelial cells is linked to mitochondrial function. Cell Growth Differ., 8: 523-532, 1997.
21. Heerdt, B. G., and Augenlicht, L. H. Effects of fatty acids on expression of genes encoding subunits of cytochrome c oxidase and cytochrome c oxidase activity in HT29 human colonic adenocarcinoma cells. J. Biol. Chem., 266: 19120-19126, 1991
22. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principles of protein-dye binding. Ann. Biochem., 72: 248-254, 1976.
23. Yang, J., Liu, X., Bhalla, K., Kim, C. N., Ibrado, A. M., Cai, Y., Peng, T-I., Jones, D. P., and Wang, X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria is blocked. Science (Washington DC), 275: 1129-1132, 1997.
24. Haldar, S., Negrini, M., Monne, M., Sabbioni, S., and Croce, C. M. Down-regulation of bcl-2 by p53 in breast cancer cells. Cancer Res., 54: 2095-2097, 1994.
25. El-Deiry, W. S., Harper, W. J., O'Connor, P. M., Velculescu, V. E., Canman, C. E., Jackman, J., Pietenpol, J. A., Burrell, M., Hill, D. E., Wang, Y., Wiman, K. G., Mercer, W. E., Kastan, M. B., Kohn, K. W., Elledge, S. J., Kinzler, K. W., and Vogelstein, B. WAF1/C1P1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
26. Dulic, V., Stein, G. H., Far, D. F., and Reed, S. I. Nuclear accumulation of p21Cip1 at the onset of mitosis: a role at the G2/M-phase transition. Mol. Cell. Biol., 18: 546-557, 1998.
27. Gong, J. Z., Zhou, H., Hu, Z., Schulman, P., Vinceguerra, V., Broome, J. D., and Koduru, P. Absence of somatic changes in p21 gene in non-Hodgkin's lymphoma and chronic myelogenous leukemia. Hematol. Pathol., 9: 171-177, 1995.
28. Hennet, T., Bertoni, G., Richter, C., and Peterhans, E. Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity, Cancer Res., 53: 1456-1460, 1993.
29. Zamzami, N., Susin, S. A., Marchetti, P., Hirsch, T., Gomez-Monterrey, I., Castedo, M., and Kroemer, G. Mitochondrial control of nuclear apoptosis. J. Exp. Med., 183: 1533-1544, 1996.
30. Decaudin, D., Geley, S., Hirsch, T., Castedo, M., Marchetti, P., Macho, A., Kofler, R., and Kroemer, G. Bcl-2 and Bel-XL antagonize the mitoehondrial dysfunction proceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res., 57: 62-67, 1997.
31. Jacobson, M. D., Burne, J. F., and Raff, M. C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J., 13: 1899-1910, 1994.
32. Schulze-Osthoff, K., Walczak, H., Droge, W., and Krammer, P. H. Cell nucleus and DNA fragmentation are not required for apoptosis. J. Cell Biol., 127: 15-20, 1994.
33. Vayssiere, J-L., Petit, P. X., Risler, Y., and Mignotte, B. Commitment to apoptosis is associated with changes in milochondrial biogenesis and activity in cell lines conditionally immortalized with simian virus 40. Proc. Natl. Acad. Sci. USA, 91: 11752-11756, 1994.
34. Marchetti, P., Castedo, M., Susin, S. A., Zamzami, N., Hirsch, T., Macho, A., Haeffner, A., Hirsch, F., Geuskens, M., and Kroemer, G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med., 184: 1155-1160. 1996.
35. Marchetti, P., Susin, S. A., Decaudin, D., Gamen, S., Castedo, M., Hirsch, T., Zamzami, N., Naval, J., Senik, A., and Kroemer, G. Apoptosis-associated derangement of mitochondrial function in cells lacking mitoehondrial DNA. Cancer Res., 56: 2033-2038, 1996.
36. Salvioli, S., Ardizzoni, A., Franceschi, C., and Cossarizza, A. JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett., 411: 77-82, 1997.
37. Cossarizza, A., Baccarani-Contri, M., Kalashnikova, G., and Franceschi, C. A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5.5′6.6′-tetrachloro-1.1′3.3′-tetraethylben- zimidazolcarbocyanine iodide (JC-1). Biochem. Biophys. Res. Commun., 30: 40-45, 1993.
38. Zou, H., Hanzel, W. J., Liu, X., Lutschg, A., and Wang, X. Apf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell, 90: 405-413, 1997.
39. Janicke, R. U., Sprengan, M. L., Wati, M. R., and Porter, A. G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem., 273: 9357-9360, 1998.
40. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
41. Wolter, K. G., Hsu, Y. T., Smith, C. L., Nechushtan, A., Xi, X. G., and Youle, R. J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol., 139: 1281-1292, 1997.
42. Goping, I. S., Gross, A., Lavoie, J. N., Nguyen, M., Jemmerson, R., Roth, K., Korsmeyer, S. J., and Shore, G. C. Regulated targeting of BAX to mitochondria. J. Cell Biol., 143: 207-215, 1998.
43. Gross, A., Jockel, J., Wei, M. C., and Korsmeyer. S. J. Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J., 17: 3878-3885, 1998.
44. Pastorino, J. G., Chen, S-T., Tafani, M., Snyder, J. W., and Farber, J. L. The overexpression of bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem., 273: 7770-7775, 1998.
45. Marzo, I., Brenner, C., Zamzami, N., Jugensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prevost, M-C., Xie, Z., Matsuyama, S., Reed, J. C., and Kroemer, G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science (Washington DC), 281: 2027-2031, 1998.
46. Eskes, R., Antonsson, B., Osen-Sand, A., Montessuit, S., Richter, C., Sadoul, R., Mazzei, G., Nichols, A., and Martinou, J-C. Bax-induced cytochrome c release from mitochondria is independent of the permeability transition pore but highly dependent on Mg2+ ions. J. Cell Biol., 143: 217-224, 1998.
47. Heerdt, B. G., Houston, M. A., Rediske, J. J., and Augenlicht, L. H. Steady state levels of messenger RNA species characterize a predominant pathway culminating in apoptosis and shedding of HT29 human colonic carcinoma cells. Cell Growth Differ., 7: 101-106, 1996.
48. Heerdt, B. G., Houston, M. A., and Augenlicht, L. H. Potentiation by short-chain fatty acids of differentiation and apoptosis in human colonic carcinoma cell lines. Cancer Res., 54: 3288-3294, 1994.
49. Guilbaud, N. F., Gas, N., Duponl, M. A., and Valette, A. Effects of differentiation-inducing agents on maturation of human MCF-7 breast cancer cells. J. Cell. Physiol., 145: 162-172, 1990.
50. Summerhayes, I. C., Lampidis, T. J., Bernal, S. D., Nadakavukaren, J. J., Nadakavukaren, K. K., Shepherd, E. L., and Chen, L. B. Unusual retention of rhodamine 123 by mitochondria in muscle and carcinoma cells. Proc. Natl. Acad. Sci. USA, 79: 5292-5296, 1982.
51. Chen, L. B., and Rivers, E. N. Mitochondria in cancer cells. In: D. Carney and K. Sikora (eds.), Genes and Cancer, pp. 127-135. New York: John Wiley and Sons, Ltd., 1990.
52. Davis, S., Weiss, M. J., Wong, J. R., Lampidis, T. J., and Chen, L. B. Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J. Biol. Chem., 260: 13844-13850, 1985.
53. Cohen, G. M. Caspases: the executioners of apoptosis. Biochem. J., 326: 1-16, 1997.
54. Marzo, I., Susin, S. A., Petit, P. X., Ravagnan, L., Brenner, C. Larochette, N., Zamzami, N., and Kroemer, G. Caspases disrupt mitochondrial membrane barrier function. FEBS Lett., 427: 198-202, 1998.
55. Susin, S. A., Zamzami, N., Castedo, M., Daugas, E., Wang, H-G., Geley, S., Fassy, F., Reed, J. C., and Kroemer, G. The central executioner of apoptosis: multiple connections between protease activation and mitochondria in Fas/APO-1/CD95-and ceramide-induced apoptosis. J. Exp. Med., 186: 25-37, 1997.
56. Green, D. R., and Reed, J. C. Mitochondria and apoptosis. Science (Washington DC), 281: 1309-1312, 1998.
57. Reed, J. C. Cytochrome c: can't live with it-can't live without it. Cell, 91: 559-562. 1997.
58. Liu, X., Kim, C. N., Yang, J., Jemmerson, R., and Wang, X. Induction of apoptotic program in cell-free extracts: requirement for dATP and Cytochrome c. Cell, 86: 147-157, 1996.
59. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., and Wang, X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell, 91: 479-489, 1997.
60. Bargou, R. C., Wagener, C., Bommert, K., Mapara, M. Y., Daniel, P. T., Arnold, W., Dietel, M., Guski, H., Feller, A., Rover, H. D., and Dorken, B. Overexpression of the death-promoting gene bax-a, which is downregulated in breast cancer, restores sensitivity to different apoptotic stimuli and reduces tumor growth in SCID mice. J. Clin. Invest., 97: 2651-2659, 1996.
61. Cote, C., Poirier, J., and Boulet, D. Expression of the mammalian mitochondrial genome. Stability of mitochondrial translation products as a function of membrane potential. J. Biol. Chem., 264: 8487-8490, 1989.
62. Cote, C., Boulet, D., and Poirier, J. Expression of the mammalian mitochondrial genome. Role for membrane potential in the production of mature translation products. J. Biol. Chem., 265: 7532-7538, 1990.
63. Eilers, M., Oppliger, W., and Schatz, G. Both ATP and an energized inner membrane are required to import a purified precursor protein into mitochondria. EMBO J., 6: 1073-1077, 1987.
64. Stuart, R. A., Nicholson, D. W., and Neupert, W. Early steps in mitochondrial protein import: receptor function can be substituted by the membrane insertion activity of apocytochrome c. Cell, 60: 31-43, 1990.
65. Mayer, A., Neupert, W., and Lill, R. Translocation of apocytochrome c across the outer membrane of mitochondria. J. Biol. Chem., 270: 12390-12397, 1995.
66. Janicke, R. U., Ng, P., Sprengart, M. L., and Porter, A. G. Caspase-3 is required for α-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J. Biol. Chem., 273: 15540-15545, 1998.